Lupin Limited — Lisinopril Exporter Profile
Indian Pharmaceutical Exporter · #2 for Lisinopril · $4.3M export value · DGFT Verified
Lupin Limited is the #2 Indian exporter of Lisinopril with $4.3M in export value and 86 verified shipments. Lupin Limited holds a 7.1% market share in Lisinopril exports across 2 countries. The company exports 38 pharmaceutical products worth $271.4M across 19 therapeutic categories.
Lupin Limited — Lisinopril Export Profile: Buyers & Destinations

Where Does Lupin Limited Export Lisinopril?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $1.6M | 36 | 52.3% |
| UNITED STATES OF AMERICA | $913.0K | 20 | 29.0% |
| SOUTH AFRICA | $588.9K | 30 | 18.7% |
Lupin Limited exports Lisinopril to 3 countries. The largest destination is UNITED STATES accounting for 52.3% of Lupin Limited's Lisinopril shipments, followed by UNITED STATES OF AMERICA (29.0%) and SOUTH AFRICA (18.7%). These destinations reflect Lupin Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Lisinopril from Lupin Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| LUPIN PHARMACEUTICAL INC | UNITED STATES | $1.3M | 28 |
| XXPINXXHARXXCEUXXCALXXINC | UNITED STATES OF AMERICA | $799.2K | 17 |
| UPD LEA GLEN, PHARMA DYNAMICS C/O | SOUTH AFRICA | $205.3K | 15 |
| LUPIN PHARMACEUTICALS INC | UNITED STATES | $200.0K | 4 |
| UPD LEA GLEN PHARMA DYNAMICS C O | SOUTH AFRICA | $175.4K | 4 |
| XXALLXXT PXXRMAXXUTIXXLS XXALTXXLLCX | UNITED STATES | $100.0K | 2 |
| UPD LEA GLEN PHARMA DYNAMICS | SOUTH AFRICA | $86.4K | 4 |
| UPD LEA GLEN PHARMA DYNAMICS C/O | SOUTH AFRICA | $64.4K | 3 |
| BLUEPOINT LABORATORIES | UNITED STATES | $50.0K | 1 |
| LUPIN PHARMACEUTICALS INC HARBORPLACE TOWER 111 | UNITED STATES | $50.0K | 1 |
Lupin Limited supplies Lisinopril to 16 buyers globally. The largest buyer is LUPIN PHARMACEUTICAL INC (UNITED STATES), followed by XXPINXXHARXXCEUXXCALXXINC (UNITED STATES OF AMERICA) and UPD LEA GLEN, PHARMA DYNAMICS C/O (SOUTH AFRICA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Lisinopril Export Value and How Much Does Lupin Limited Contribute?
India exported $15.9M worth of Lisinopril through 3,514 shipments from 221 suppliers to 94 countries, serving 450 buyers globally. Lupin Limited contributes $4.3M to this total, accounting for 7.1% of India's Lisinopril exports. Lupin Limited ships Lisinopril to 3 countries through 16 buyers.
What Is the Average Shipment Value for Lupin Limited's Lisinopril Exports?
Lupin Limited's average Lisinopril shipment value is $50.0K per consignment, based on 86 shipments totaling $4.3M. The largest destination is UNITED STATES (52.3% of Lupin Limited's Lisinopril exports).
How Does Lupin Limited Compare to Other Indian Lisinopril Exporters?
Lupin Limited ranks #2 among 221 Indian Lisinopril exporters with a 7.1% market share. The top 3 exporters are LUPIN LIMITED ($4.3M), IPCA LABORATORIES LIMITED ($2.7M), MICRO LABS LIMITED ($1.9M). Lupin Limited processed 86 shipments to 2 destination countries.
What Lisinopril Formulations Does Lupin Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| LISINOPRIL&HCTZ TAB USP 20/12.5MG-100'S. | $303.0K | 7 |
| LISINOPRIL TAB USP 5MG-1000'S(US). | $226.4K | 5 |
| LISINOPRIL TAB USP 5MG-1000'SUS. | $226.1K | 5 |
| LISINOPRIL&HCTZ TAB USP 20/25MG-100'S. | $200.0K | 4 |
| LISINOPRIL&HCTZ TAB USP 20/12.5MG-500'S. | $150.0K | 3 |
| LISINOPRIL TAB USP 40MG-1000'SUS R2. | $145.8K | 3 |
| LISINOPRIL TAB USP 10MG-1000'SUS R1. | $100.0K | 2 |
| LISINOPRIL TAB USP 20MG-100'SUS R1. | $100.0K | 2 |
| LISINOPRIL&HCTZ TAB USP 20/25MG-500'S. | $100.0K | 2 |
| LISINOPRIL&HCTZ TAB USP 10/12.5MG-100'S. | $100.0K | 2 |
Lupin Limited exports 44 distinct Lisinopril formulations including tablets, capsules, syrups, and combination drugs. The top formulation is LISINOPRIL&HCTZ TAB USP 20/12.5MG-100'S. with 7 shipments worth $303.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
Regulatory Requirements: Exporting Lisinopril to Key Markets
What Lupin Limited must comply with to export Lisinopril to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
South Africa — SAHPRA
Approval Process
Registration under SAHPRA guidelines (CTD format). Bioequivalence required for generics.
Timeline: 24–48 months (significant backlog)
GMP & Export Requirements
WHO GMP or PIC/S GMP compliance
Certificate of Pharmaceutical Product from CDSCO; Import permit per Section 22A of Medicines Act
Note: Known registration backlog. WHO Prequalification significantly assists the process.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Lupin Limited Compare to Nearest Lisinopril Exporters?
Exporters ranked immediately above and below #2 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | LUPIN LIMITED ★ | $4.3M | 86 | 2 | $50.0K |
| 3 | IPCA LABORATORIES LIMITED | $2.7M | 418 | 10 | $6.4K |
| 4 | MICRO LABS LIMITED | $1.9M | 50 | 5 | $38.7K |
Lupin Limited ranks #2 among 221 Indian Lisinopril exporters. Average shipment value of $50.0K compared to the market average of $72.1K. The closest competitors by value are IPCA LABORATORIES LIMITED and MICRO LABS LIMITED.
Which Indian Ports Ship Lisinopril Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 597 | 17.0% |
| DELHI AIR CARGO ACC (INDEL4) | 514 | 14.6% |
| SAHAR AIR | 509 | 14.5% |
| DELHI AIR | 282 | 8.0% |
| NHAVA SHEVA SEA (INNSA1) | 238 | 6.8% |
| Bombay Air | 172 | 4.9% |
| HYDERABAD ICD (INSNF6) | 112 | 3.2% |
| Delhi Air | 110 | 3.1% |
What Other Cardiovascular Products Does Lupin Limited Export?
Lupin Limited also exports these cardiovascular products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Lupin Limited's Lisinopril Exports
Lupin's export operations are influenced by various geopolitical factors. The ongoing Israel-Iran tensions have led to increased security risks in the Red Sea, prompting major shipping lines to implement 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, thereby escalating shipping costs for Indian exporters. (sgexports.odoo.com) Additionally, the 2025 United States–India diplomatic and trade crisis resulted in the U.S. imposing a 50% tariff on Indian exports, significantly affecting the competitiveness of Indian pharmaceutical products in the U.S. market. (en.wikipedia.org)
Conversely, the European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) poses compliance challenges for Indian exporters, including Lupin, necessitating adherence to stringent carbon reporting requirements. However, the EU's focus on reducing dependency on Chinese pharmaceutical imports presents an opportunity for Indian companies to capture a larger share of the European market.
Lupin Limited — Regulatory Compliance & Quality Standards
Maintaining stringent quality standards is paramount for Lupin's global operations. In February 2025, the U.S. FDA completed a Pre-Approval Inspection at Lupin's Somerset, New Jersey facility with zero observations, reflecting the company's commitment to compliance and quality. (lupin.com) However, the evolving regulatory landscape, including the EU's falsified medicines directive and the U.S. FDA's increasing scrutiny, necessitates continuous investment in quality assurance and regulatory compliance to ensure uninterrupted market access.
About Lupin Limited
Lupin Limited exports 38 products worth $271.4M. Beyond Lisinopril, top products include Isoniazid, Cephalexin, Simvastatin, Rifampicin, Amlodipine. View the complete Lupin Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Lisinopril — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Lisinopril shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Lupin Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 86 individual customs records matching Lupin Limited exporting Lisinopril, covering 44 formulations to 3 countries via 16 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 94+ countries, 450+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Lisinopril Export Data from Lupin Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Lupin Limited's Lisinopril exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Lupin Limited
Full Company Profile →
38 products · $271.4M total trade · 19 categories
Lisinopril Stats
Company Overview
Top Products by Lupin Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Lupin Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Lisinopril. For current shipment-level data, contact TransData Nexus.